Stay updated on SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns medical and healthcare-related publications and documentation, specifically regarding the eligibility criteria for patients with advanced pancreas adenocarcinoma in a clinical trial study.
    Difference
    47%
    Check dated 2024-05-22T07:38:32.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    16 days ago
    Change Detected
    Summary
    The value '02 05' has been updated to '05 09' on the webpage, indicating a change in the date of the last update posted regarding the randomized treatment plan for patients with advanced pancreas adenocarcinoma receiving standard of care chemotherapy followed by adaptive stereotactic body radiotherapy with concurrent and adjuvant FAK inhibitor defactinib in the experimental arm.
    Difference
    13%
    Check dated 2024-05-10T08:13:55.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:17:44.000Z thumbnail image

Stay in the know with updates to SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.